KUROS BIOSCIENCES AG-REG/ CH0325814116 /
11/10/2024 17:16:11 | Chg. +1.68 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
19.76CHF | +9.29% | 10,313 Turnover: 203,401.31 |
-Bid Size: - | -Ask Size: - | 724.65 mill.CHF | - | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | -0.38 CHF | -11.63% |
EPS Diluted: | - CHF | 65.22% |
Revenues per Share: | 0.92 CHF | 86.57% |
Book Value per Share: | 1.55 CHF | -17.64% |
Cash Flow per Share: | -0.24 CHF | 20.33% |
Dividend per Share: | - CHF | - |
Total | in mill. | |
Revenues: | 33.56 CHF | 86.57% |
Net Income: | -13.73 CHF | -5.98% |
Operating Cash Flow: | -8.84 CHF | - |
Cash and Cash Equivalents: | 14.21 CHF | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | - | - |
P/S Ratio: | 21.59 | 3.80 |
P/BV ratio: | 12.78 | 2.25 |
P/CF Ratio: | -81.94 | -14.43 |
PEG: | 4.49 | - |
Earnings Yield: | -1.92% | -10.89% |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 724.65 mill. CHF | 127.6 mill. CHF |
Free Float Market Cap.: | - CHF | - CHF |
Market Cap. / Employee: | 9.06 mill. CHF | 1.59 mill. CHF |
Shares Outstanding: | 36.56 mill. |
Profitability
Gross Profit Margin: | 71.31% |
EBIT Margin: | -39.30% |
Net Profit Margin: | -40.90% |
Return on Equity: | -24.20% |
Return on Assets: | -19.21% |
Financial Strength
Liquidity I / Cash Ratio: | 107.74% |
Liquidity II / Quick Ratio: | 156.36% |
Liquidity III / Current Ratio: | 206.22% |
Debt / Equity Ratio: | 26.01% |
Dynam. Debt / Equity Ratio: | -166.80% |
Efficiency
Employees: | 80 |
Personal Expenses / Employee: | - CHF |
Revenues / Employee: | 419,550.00 CHF |
Net Income / Employee: | -171,587.50 CHF |
Total Assets / Employee: | 893,300.00 CHF |
* Fiscal Year End: | 31/12/2023 |
Accounting Standard: | IFRS |
Currency: | CHF |